Home / Investors / Startups / Signos

Signos

Signos pairs glucose data with an AI-enhanced app to bring visibility into metabolic function and guidance to drive health and weight loss.

About Signos

Signos is on a mission to tackle the obesity epidemic via healthy habits, glucose level stabilization, and AI. Signos combines continuous glucose information with an AI-enhanced app to offer revolutionary continuous data and recommendations designed to drive healthy and sustained weight loss. With over 75% of the American population overweight or obese, Signos provides a new way for people to act on their body’s unique response to what they eat to lose weight and kickstart a healthier life

Industries

Investors in Signos (5)